Big pharma reaps big profits from single drugs

08/21/2013 | Quartz

Of the world's 11 largest pharmaceutical companies, six market a single drug that represented more than 10% of their total sales last year, according to journalist David Yanofsky. The company with the biggest portion of net sales in one drug was Abbott Laboratories with its rheumatoid arthritis treatment Humira, which accounted for more than 23% of the firm's sales, followed by Eli Lilly & Co., whose antidepressant Cymbalta made up more than 22% of net sales. The big exception: highly diversified Bayer, with no single product taking more than 5% of sales.

View Full Article in:

Quartz

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA